The DSO De Novo Boom: Why Dental Groups Are Building Instead of Buying

Bypaulgruensfelder
Free tool
What might a practice like this be worth?

Turn adjusted EBITDA and a few practice details into a directional enterprise-value range with our Healthcare Practice Valuation Calculator. Educational and directional, and no email required.

Open the calculator →
Becker’s Dental Review April 21, 2026
Read Full Article →
AI-Generated Summary

Several DSOs are diversifying beyond acquisitions by ramping up de novo practice development, a shift driven by tighter deal supply, valuation pressure, and the operational appeal of building from scratch. Smile Partners launched its first de novo as a deliberate break from its acquisition-only model, while Park Dental Partners is directing post-IPO capital toward new office openings in existing markets. The appeal is practical: de novos offer DSOs full control over patient experience, staffing culture, and brand consistency from day one, without integration costs of acquired practices. At a moment when acquisition targets are harder to find and multiples remain elevated, de novo development is emerging as a high-conviction growth strategy for platforms with strong operational infrastructure.

Why It Matters

For PE-backed dental platforms weighing capital deployment, this piece captures the de novo shift in concrete terms — naming specific DSOs making the pivot. Operators should assess their own organic development capacity now, before competitive density in key markets makes de novo economics harder to justify.

DSO de novo growth dental practice expansion DSO strategy 2026 organic growth practice development dental M&A

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

Why are DSOs increasingly pursuing de novo development over acquisitions?

De novo development is gaining favor as practice supply tightens and acquisition multiples rise. Building from scratch eliminates the premium paid for existing patient panels and goodwill, allows DSOs to install their own systems and culture from day one, and provides control over location, design, and provider selection. Organizations like Smile Partners have launched dedicated de novo programs as a core growth pillar alongside acquisitions.

What are the primary risks of de novo dental practice development?

The main risk is ramp time — a new practice typically takes 18 to 36 months to reach mature production levels, generating losses during that period. Real estate selection is difficult to reverse. Provider recruitment for new locations is often harder than retaining an acquired practice’s existing dentist. DSOs managing large de novo pipelines need strong cash reserves and conservative production ramp assumptions in their financial models.

How do de novo economics compare to acquisition economics for DSOs?

De novo development typically requires lower upfront capital than acquisition since there is no goodwill payment, but carries higher execution risk and longer payback periods. Well-located de novos in high-growth markets can generate superior long-term returns compared to acquisitions at 7x to 10x EBITDA — but only when site selection, provider recruitment, and ramp support are executed at a consistently high level.

Similar Posts

  • Google Opens Gemini Business-Profile Management to Multi-Location Accounts

    Bypaulgruensfelder

    Yes — as of August 2026, Google’s Gemini integration for Google Business Profile now works for accounts managing multiple locations, and it is globally available on desktop and mobile. Google confirmed the change in its August Small Business Bulletin, narrowing the single-profile restriction that had limited the June 10 launch to one feature (business notebooks). Gemini drafts and suggested edits run through official Business Profile APIs under the same verification standards as manual changes, and nothing publishes without owner sign-off. The integration is free but currently supports only personal Gmail accounts — Workspace support, which agencies and enterprises rely on, is still “in the works.” Google also stresses that appearing in AI search requires quality content and complete profile data, not special code.

  • MGMA 2026: Only 47% of Medical Groups Report Rising Revenue as Costs Climb

    Bypaulgruensfelder

    Medical practice revenue growth is stalling in 2026 even as costs keep climbing. MGMA’s June 30, 2026 poll found just 47% of medical groups reporting higher year-to-date revenue versus 2025, with 36% reporting a decline—narrowing the gainers’ lead from 26 points a year ago to only 11. Meanwhile 84% report higher operating costs. Two forces drive the squeeze: the 2026 Medicare Physician Fee Schedule’s -2.5% work-RVU efficiency adjustment on 7,000+ procedural codes, and ACA marketplace erosion—effectuated enrollment fell to 19.2 million, roughly 3 million below 2025, as average deductibles jumped 37% to a record $3,786. MGMA urges practices to model Medicare impact by CPT code and refresh payer-mix projections now.

  • Jarrard 2026 Survey: Community Impact Drives Hospital Trust and Patient Choice

    Bypaulgruensfelder

    Hospitals seen as strong community partners earn markedly higher consumer trust, advocacy, and preference, according to Jarrard’s 2026 Community Impact Survey — yet fewer than one-third of consumers strongly agree their local hospital is a good community partner. Consumers who do hold that view are 26 points more likely to trust the hospital to do the right thing, 37 points more likely to speak positively about or defend it, 33 points more likely to advocate for it on policy issues, and 24 points more likely to choose it when all else is equal (15 points more likely even when less convenient). Jarrard frames visible community impact as a business imperative tied directly to loyalty and choice.

  • ADA Q2 2026: Dental Fiscal Squeeze Persists as AI Adoption Hits 43%

    Bypaulgruensfelder

    Dentists’ economic confidence rose in Q2 2026 even as a persistent “fiscal squeeze” pressures practice margins: since January 2021, dental equipment, supplies, and staff wages have each climbed 23% while all-payer reimbursement rose just 19%, trailing 27% inflation. Consumer dental spending is up only 1% year-over-year ($216 billion annualized) and has lagged physician and overall health spending over the past decade. Dentists report being busier, with new-patient wait times at 13.9 days, and dental-office employment is up 1.5%. On AI, 43% of dentists now use it — most often for imaging and diagnostics — while four in five reject AI for treatment recommendations, citing the need for clinical judgment. Based on 552 private-practice responses.

  • Hospital Mergers as a Lifeline: What Actually Creates Value

    Bypaulgruensfelder

    Hospital mergers are increasingly a survival move rather than a growth play, as roughly $1 trillion in Medicaid cuts under the One Big Beautiful Bill Act and ACA changes squeeze margins and raise uncompensated care. Independent and rural hospitals that lack capital for technology and service expansion are seeking larger partners, but stricter state regulatory reviews now threaten deal timelines — Oregon’s Santiam Hospital warned it could become insolvent by August 1 without an expedited merger. Optum Advisory’s Morgan Haines stresses that “the merger itself is never the value”; stabilization comes from post-close investments in technology, service-line redesign, operational improvements, and community partnerships. Leaders are urged to prioritize “speed-to-value.”

  • Why AI ROI Stalls: The Case for Disciplined Decisions

    Bypaulgruensfelder

    AI initiatives often underdeliver because organizations never define which decisions AI should actually improve — a fixable focus problem, not a technology gap. Summit Partners’ Sharon Lin argues that generative AI has lowered the cost of analysis so dramatically that many teams now face “analysis paralysis at scale,” producing endless dashboards and scenarios while struggling to act. She warns against automating away interpretive, relational work — consultative sales, creative brainstorming, customer insight — where friction itself carries signal. The limiting factor in AI-enabled organizations is rarely access to insight or technology; it is the discipline to identify which decisions AI can genuinely improve and the willingness to protect space for human judgment.